[Federal Register Volume 67, Number 95 (Thursday, May 16, 2002)]
[Notices]
[Page 34947]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-12219]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group Treatment Research Subcommittee.
    Date: June 19-20, 2002.
    Time: 9 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Swissotel Washington, The Watergate, 2650 Virginia Ave., 
NW., Washington, DC 20037.
    Contact Person: Kesinee Nimit, MD, Health Scientist 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-
1432.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group Health Services Research Subcommittee.
    Date: June 19-20, 2002.
    Time: 9 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Swissotel Washington, The Watergate, 2650 Virginia Ave., 
NW., Washington, DC 20037.
    Contact Person: Marina L. Volkov, PhD, Health Scientist 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-
1433.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel Treatment Research.
    Date: June 19, 2002.
    Time: 1 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Swissotel Washington, The Watergate, 2650 Virginia Ave., 
NW., Washington, DC 20037.
    Contact Person: Mark R. Green, PhD, Chief, CEASRB, Office of 
Extramural Affairs, National Institute on Drug Abuse, National 
Institutes of Health, DHHS, Room 3158, MSC 9547, 6001 Executive 
Boulevard, Bethesda, MD 20892-9547, (301) 435-1431.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group Training and Career Development Subcommittee.
    Date: June 25-26, 2002.
    Time: 9 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Residence Inn, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: Mark Swieter, PhD, Health Scientist 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-
1389.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group Medication Development Research Subcommittee 
Medications Development Research Subcommittee.
    Date: July 15, 2002.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt at Fisherman's Wharf, 555 North Point Street, San 
Francisco, CA 94133.
    Contact Person: Khursheed Asghar, PhD, Chief, Basic Sciences 
Review Branch, Office of Extramural Affairs, National Institute on 
Drug Abuse, National Institutes of Health, 6001 Executive Boulevard, 
Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443-2620.

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse Research Programs, National Institutes of Health, 
HHS)

    Dated: May 9, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-12219 Filed 5-15-02; 8:45 am]
BILLING CODE 4140-01-M